D-Aspartate oxidase (DDO) is a degradative enzyme that acts stereospecifically on free acidic D-amino acids such as D-aspartate and D-glutamate. D-Aspartate plays an important role in regulating neurotransmission, developmental processes, hormone secretion, and reproductive functions in mammals. In contrast, the physiological role of D-glutamate in mammals remains unclear. In Caenorhabditis elegans, the enzyme responsible for in vivo metabolism of D-glutamate is DDO-3, one of the three DDO isoforms, which is also required for normal self-fertility, hatching, and lifespan. In general, eukaryotic DDOs localize to subcellular peroxisomes in a peroxisomal targeting signal type 1 (PTS1)-dependent manner. However, DDO-3 does not contain a PTS1, but instead has a putative N-terminal signal peptide (SP). In this study, we found that DDO-3 is a secreted DDO, the first such enzyme to be described in eukaryotes. In hermaphrodites, DDO-3 was secreted from the proximal gonadal sheath cells in a SP-dependent manner and transferred to the oocyte surface. In males, DDO-3 was secreted from the seminal vesicle into the seminal fluid in a SP-dependent manner during mating with hermaphrodites. In both sexes, DDO-3 was secreted from the cells where it was produced into the body fluid and taken up by scavenger coelomocytes. Full-length DDO-3 transgene rescued all phenotypes elicited by the deletion of ddo-3, whereas a DDO-3 transgene lacking the putative SP did not. Together, these results indicate that secretion of DDO-3 is essential for its physiological functions.
Introduction
D-Aspartate oxidase (DDO) is a degradative enzyme that stereospecifically acts on free acidic D-amino acids such as D-aspartate (D-Asp) and D-glutamate (D-Glu). This enzyme activity was first reported in rabbit kidney extracts in 1949 [1] . DDO is a flavin adenine dinucleotide (FAD)-containing flavoprotein [2] that catalyzes oxidative deamination of D-amino acids in the presence of H 2 O and O 2 to produce a-keto acids, hydrogen peroxide (H 2 O 2 ), and ammonia [3] . In mammals, DDO activity is highest in the kidney, followed by liver and brain, but low in other peripheral tissues [2, 4] . Two groups have independently established DDO-deficient mice and shown that these mice have significantly elevated levels of D-Asp in multiple tissues [5, 6] . Therefore, mammalian DDO is presumed to regulate the levels of endogenous and exogenous D-Asp in various organs, although its physiological roles remain to be fully elucidated.
Substantial amounts of D-Asp are present in a wide variety of tissues and cells in both invertebrates and Abbreviations DDO, D-aspartate oxidase; DIC, differential interference contrast; FAD, flavin adenine dinucleotide; NMDA, N-methyl-D-aspartate; PTS1, peroxisomal targeting signal type 1; SP, signal peptide.
vertebrates, particularly those that make up the central nervous, neuroendocrine, and endocrine systems. In mammals, D-Asp plays important roles in regulating developmental processes, hormone secretion, and reproductive functions [7, 8] . For instance, in the rat testis, D-Asp enhances testosterone synthesis in Leydig cells by promoting the expression of steroidogenic acute regulatory protein, a key regulatory protein that facilitates the rate-limiting step in testosterone synthesis [9, 10] . Moreover, administration of D-Asp to mouse spermatogonial GC-1 cells enhances the cell proliferation [11] . The involvement of D-Asp in the maturation of gonads, as well as testosterone synthesis and spermatogonial proliferation, has also been demonstrated by studies of seasonal-breeding vertebrates [12] [13] [14] [15] . D-Asp is also proposed to regulate brain functions by binding to the N-methyl-D-Asp (NMDA) receptor (a subtype of the L-Glu receptor family) as an endogenous agonist [7, 16] . This idea is supported by recent reports demonstrating that D-Asp levels are reduced, and DDO enzyme activity is elevated, in the prefrontal cortex of postmortem brains of patients with schizophrenia, a disease associated with NMDA receptor dysfunction [17, 18] . On the other hand, free D-Glu, the other substrate of DDO, is present in various mammalian tissues at relatively low levels [19] [20] [21] , but its physiological role remains unclear.
To understand the physiological functions of Damino acids at the molecular level, we used the nematode Caenorhabditis elegans as an experimental model. This animal has two sexes: self-fertilizing hermaphrodite and male; the latter is rare. The life cycle consists of an embryonic stage, four larval (L1-L4) stages, and an adult stage. In previous reports, we demonstrated that D-Asp, D-Glu, D-alanine (D-Ala), and D-serine are present in C. elegans throughout life [22, 23] , and that C. elegans has three genes (ddo-1, ddo-2, and ddo-3) encoding functional DDOs [24, 25] . Furthermore, using deletion mutants of these genes, we demonstrated that DDO-1 and DDO-3 are responsible for the in vivo metabolism of D-Asp and D-Glu, respectively [22] . Phenotypic analyses of the mutants revealed that all DDOs participate in the fertility and hatching processes of C. elegans, implying the involvement of these enzymes in the reproductive activity. In addition, our analyses suggested the involvement of DDO-3, but not DDO-1 or DDO-2, in regulation of growth and lifespan.
Eukaryotic DDO localizes to subcellular peroxisomes in a peroxisomal targeting signal type 1 (PTS1)-dependent manner [2, 26, 27] . Because peroxisomes contain catalase, a H 2 O 2 -degrading enzyme, the localization of DDO to peroxisomes protects the cell against the toxicity of H 2 O 2 generated by the DDO-catalyzed reaction. In C. elegans, DDO-1 is presumed to localize to peroxisomes due to the presence of a PTS1 sequence at its C terminus [25] . On the other hand, DDO-2 does not contain any known signal sequences for organellar localization, and may therefore localize to the cytoplasm. Interestingly, DDO-3 is annotated in WormBase (http://www.wormbase.org/) as a secretory protein due to the presence of a putative signal peptide (SP) at its N terminus. To date, however, no study has experimentally verified that DDO-3 is actually secreted into the extracellular space. Furthermore, the detailed relationships between the localization of DDO-3 and the phenotypes of the ddo-3 mutant, such as the reductions of self-brood size and hatching rate and the extension of lifespan, remain to be elucidated.
In this study, we first sought to confirm that DDO-3 is actually secreted. To this end, we first generated transgenic worms carrying a transcriptional reporter, allowing us to monitor the expression pattern of DDO-3. We also generated transgenic worms carrying translational reporters, enabling us to investigate the localization patterns of DDO-3 with or without the putative SP. The results revealed that DDO-3 is indeed secreted to the extracellular space and localized in cells other than those that express the ddo-3 gene. We then asked whether the secretion of DDO-3 is required for its physiological functions; in particular, we investigated whether a DDO-3 transgene lacking the putative SP could rescue the phenotypes of the ddo-3 mutant. The results revealed that secretion of DDO-3 is essential for normal self-fertility, hatching, lifespan, and nose touch response in C. elegans. This is the first report of a secreted isoform of DDO.
Results
In hermaphrodites, DDO-3 is secreted from proximal gonadal sheath cells and transferred to the oocyte surface The DDO-3 does not have a C-terminal PTS1 and is predicted to be a secretory protein. Indeed, PSORT II analysis [28] predicted that DDO-3 has an N-terminal SP with a cleavage site located between positions 14 and 15 (Fig. 1A) . Moreover, DDO-3 contains a FADbinding consensus sequence (GXGXXG) that does not overlap with the putative SP (Fig. 1A) . Therefore, we presumed that DDO-3 is a secretory protein with functional DDO enzyme activity. Moreover, because secreted DDO-3 could be relocalized to other cells, we predicted that its sites of expression and localization might differ in vivo. To examine the expression sites of DDO-3 in C. elegans, we generated transgenic lines carrying the following two reporter genes: Pddo-3:: mCherry, in which mCherry is expressed under the control of the ddo-3 promoter; and ddo-3 SP(À):: mCherry, in which mCherry N-terminally fused with the putative SP-lacking DDO-3 is expressed under the control of the ddo-3 promoter (hereafter, the protein products of these genes are referred to as Pddo-3:: mCherry and DDO-3 SP(-)::mCherry, respectively; Fig. 1B ). To examine the localization sites of DDO-3, we generated additional transgenic lines carrying the ddo-3::mCherry reporter, in which mCherry N-terminally fused with full-length DDO-3 is expressed under the control of the ddo-3 promoter (hereafter, the protein product of this gene is referred to as DDO-3:: mCherry; Fig. 1B) .
In hermaphrodites, the expression of Pddo-3:: mCherry was observed in the excretory pore cell from the late embryonic stage ( Fig. 2A-B 0 , D, and D 0 ), in head tip cells from larval stage L3 (Fig. 2B-C 0 ), in vulval cells from L4 ( Fig. 2F and F 0 ), and in hypodermal cells ( Fig. 2E and E 0 ) and proximal gonadal sheath cells ( Fig. 2G and 2G 0 ) from the adult stage. The expression pattern of DDO-3 SP(À)::mCherry was consistent with that of Pddo-3::mCherry (Fig. 2H-L 0 , N, and N 0 ), except that no expression of DDO-3 SP 
Schematic representation of genomic structure of ddo-3 and the reporter constructs used in this study. Open, gray, light blue, and magenta boxes indicate the ddo-3 untranslated region, ddo-3 coding exon, putative SP, and mCherry cDNA, respectively. The positions of the initiation codons (ATG), stop codons (TAG and TGA), and tm2028 deletion are indicated. In the Pddo-3::mCherry reporter construct, mCherry is expressed under the control of the ddo-3 promoter. In the ddo-3 SP(À)::mCherry reporter construct, mCherry N-terminally fused with DDO-3 lacking the putative SP is expressed under the control of the ddo-3 promoter. In the ddo-3::mCherry reporter construct, mCherry N-terminally fused with full-length DDO-3 is expressed under the control of the ddo-3 promoter. 
:mCherry was observed in vulval cells at any point during development ( Fig. 2M and M 0 ). These results suggested that, in hermaphrodites, DDO-3 is expressed in the excretory pore cell, head tip cells, hypodermal cells, and proximal gonadal sheath cells, and that the structural gene sequence of ddo-3 may inhibit its vulval expression through an unidentified mechanism.
Consistent with the expression patterns of these two reporter proteins, DDO-3::mCherry was also localized in the excretory pore cell (Fig. 3B-C 0 , E, and E 0 ), head tip cells (Fig. 3C-D 0 ), and hypodermal cells ( Fig. 3F and F 0 ). On the other hand, DDO-3::mCherry was not localized in proximal gonadal sheath cells at any point during development ( Fig. 3H and H 0 ), suggesting that DDO-3 is secreted from these cells in a SP-dependent manner. Interestingly, in the adult stage, DDO-3:: mCherry was localized on the surface of the oocyte, which is surrounded by gonadal sheath cells ( Fig. 3H and H 0 ), suggesting that DDO-3 produced in and secreted from proximal gonadal sheath cells is transferred to the oocyte surface. Furthermore, DDO-3:: mCherry was also localized in the eggshell within the adult uterus, as well as in the uterine space ( Fig. 3G and G 0 ), and it remained localized in the eggshell until hatching (Fig. 3A-B 0 ). The localization of DDO-3:: mCherry to the oocyte surface, uterine space, and eggshell was striking given the lack of Pddo-3::mCherry and DDO-3 SP(-)::mCherry expression in both tissues ( Fig. 2A, A 0 , F-H 0 , and M-N 0 ). Together, these results suggest that DDO-3 expressed in proximal gonadal sheath cells is secreted to the extracellular space in a SP-dependent manner and localized to the surface of an adjacent oocyte, and eventually reaches the uterine space and eggshell.
In males, DDO-3 is secreted from the seminal vesicle into the seminal fluid during mating
In males, Pddo-3::mCherry was expressed in the excretory pore cell, head tip cells, and hypodermal cells (data not shown), in a pattern similar to that observed in hermaphrodites. Moreover, this reporter protein was expressed in seminal vesicle cells from L4 ( Fig. 4A and A 0 ) and in tail cells and spicule cells from the adult stage ( Fig. 4B and B 0 ). The expression pattern of DDO-3 SP(À)::mCherry was consistent with that of Pddo-3::mCherry (data not shown and . In contrast, DDO-3::mCherry was also localized in the tail fan from the adult stage ( Fig. 4F and F 0 ), suggesting that DDO-3 is secreted in a SP-dependent manner from the cells where it is produced and transferred to the tail fan.
Interestingly, DDO-3::mCherry was localized in vesicle-like structures in the seminal vesicle, where spermatids are stored until ejaculation ( Fig. 4E and E 0 ). Because the seminal vesicle is composed of 20 secretory cells [29] , we presumed that DDO-3 was secreted from the seminal vesicle into the seminal fluid and transferred to the hermaphrodite during mating. To test this possibility, we examined the uteri of hermaphrodites just after mating with transgenic males carrying the ddo-3::mCherry reporter gene. DDO-3::mCherry was dispersed throughout the uterus (Fig. 4G and G 0 ), suggesting that DDO-3 is a seminal fluid protein.
Taken together, these results are consistent with the idea that DDO-3 is secreted from the seminal vesicle into the seminal fluid in a SP-dependent manner, and then transferred to the hermaphrodite uterus through mating.
In both sexes, DDO-3 is secreted into the body fluid by the cells that produce it, and then taken up by coelomocytes
In hermaphrodites, in addition to the excretory pore cell, head tip cells, hypodermal cells, oocyte surface, uterine space, and eggshell, DDO-3::mCherry was also present in coelomocytes from the late embryonic stage, and accumulated in vesicle-like structures at least from the adult stage (Fig. 3B-C 0 , E, E 0 , and G-H 0 ). This fusion protein was also present in coelomocytes of males ( Fig. 4F and F 0 ). Because coelomocytes are scavenger cells that continuously and nonspecifically endocytose fluid from the body cavity [30] , these results suggested that DDO-3 is secreted into the body fluid in a SP-dependent manner from the cells that produce it, and is then taken up by coelomocytes, in which it is degraded. During larval stages L1 and L2, localization of DDO-3::mCherry outside coelomocytes was limited to the excretory pore cell, implying that DDO-3 expressed in excretory pore cells is secreted into the body fluid. Indeed, at least in the adult stage, DDO-3::mCherry in excretory pore cells was localized to vesicle-like structures ( Fig. 3E and E 0 ).
Secretion of DDO-3 is required for normal selffertility, hatching, lifespan, and nose touch response
Previously, we demonstrated that, in comparison with the wild-type C. elegans, ddo-3(tm2028) (a ddo-3 deletion mutant strain) hermaphrodites exhibit reduced self-brood size, reduced hatching rate, and extended lifespan [22] . In this study, to further investigate the physiological significance of DDO-3, we examined various behaviors of ddo-3 mutant hermaphrodites and males. ddo-3 mutant hermaphrodites were apparently normal for a number of behaviors tested, such as feeding, defecation, and locomotion (Table 1 ). In contrast, the nose touch response of ddo-3 mutant hermaphrodites was significantly impaired relative to that of wildtype animals, although the mutant hermaphrodites responded normally to anterior and posterior body touches (Table 1) . Because DDO-3 was present in the seminal fluid and the tissues related to male fertility such as the seminal vesicle, spicule, and fan (Fig. 4) , we examined the mating efficiency of the ddo-3 mutant males. Mated hermaphrodites produce predominantly cross-progeny due to the competitive superiority of male-derived sperm [31] . When ddo-3 mutant males were individually crossed with wild-type recipient hermaphrodites, the number of cross-progeny was not significantly different from the number derived from matings with wild-type males (Table 1) . Thus, ddo-3 mutant males exhibited no obvious defects in male fertility.
To determine whether secretion of DDO-3 is required for normal self-fertility, hatching, nose touch response, and lifespan, we performed rescue experiments. Specifically, we asked whether the phenotypes of the ddo-3 mutant could be rescued by introduction of the ddo-3 or ddo-3 SP(À) transgene under the control of the ddo-3 promoter; these transgenes encode full-length DDO-3 and a DDO-3 lacking the putative SP, respectively. As expected, the reductions in selfbrood size, hatching rate, and nose touch response, as well as the extension of lifespan, were rescued by expression of the ddo-3 transgene; similar results were obtained in three independently established transgenic lines (Fig. 5) . In contrast, none of these phenotypes were rescued by expression of the ddo-3 SP(À) transgene (Fig. 5) . Taken together, these results suggested that secretion of DDO-3 to the extracellular space in a SP-dependent manner is required for its physiological function(s) in self-fertility, hatching, nose touch response, and lifespan of C. elegans.
Discussion
The results obtained in this study suggest that extracellular trafficking of secreted DDO-3 to the oocyte surface is important for normal self-fertility and hatching in C. elegans. The hermaphrodite reproductive system consists of two symmetrical U-shaped gonad arms that are joined to a common uterus through the spermatheca [31] . Spermatids are produced during the last larval stage and stored in the spermatheca. Subsequently, in the adult stage, gonadal function switches from spermatid production to oocyte production. Oocytes undergo meiotic maturation as they move toward the uterus, and are then ovulated into the spermatheca. In the spermatheca, spermatids undergo dramatic morphogenesis to become mature spermatozoa (sperm), a process termed 'sperm activation' [32] ; the sperm then fertilize the mature oocytes. The molecular details of sperm activation remain unclear, but recent work showed that H 2 O 2 produced by superoxide dismutase SOD-2 activates sperm in C. elegans [33] . These observations imply that H 2 O 2 produced from DGlu by DDO-3 on the oocyte surface also plays an essential role in activating sperm, leading to efficient self-fertilization in hermaphrodites. In ddo-3 mutant hermaphrodites, H 2 O 2 production on the oocyte surface may be reduced, resulting in insufficient sperm activation and ultimately decreasing self-brood size (Fig. 5A) . Moreover, the zygotes generated under these conditions may undergo abnormal embryogenesis, resulting in a reduction in the hatching rate (Fig. 5B) . Thus, it appears that the binding of the secreted DDO-3 to the oocyte surface is important for normal self-fertility and hatching. However, the target molecule(s) of the secreted DDO-3 remains unclear. Mass spectrometric analysis of immunoprecipitates of lysate of transgenic worms expressing DDO-3:: mCherry with anti-mCherry antibody will likely aid in identifying the target molecule(s) of the secreted DDO-3 in C. elegans.
Our findings revealed that, in males, DDO-3 is present in the seminal fluid and tissues related to male fertility (Fig. 4E-G 0 ). Nevertheless, mating efficiency did not differ significantly between ddo-3 mutant and wildtype males (Table 1) . Male-derived sperm are activated in the hermaphrodite uterus when a male copulates with the hermaphrodites; the activated sperm crawl up the uterus to the spermatheca and preferentially fertilize the oocytes [34] . In the experiment examining male mating efficiency in crosses between ddo-3 mutant males and wild-type hermaphrodites, the hermaphrodite-derived DDO-3 in the uterus may have been sufficient to activate the male-derived sperm via H 2 O 2 produced from D-Glu. Hence, mating efficiency with wild-type hermaphrodites may not reflect the difference in the level of DDO-3 in the seminal fluid between ddo-3 mutant and wild-type males. Analysis of male mating efficiency using ddo-3 mutant hermaphrodites will likely aid our understanding of the physiological role(s) of DDO-3 secreted into the seminal fluid. Behaviors were assayed as described in the Materials and methods section. Data are shown as means AE SEM (n). No significant difference (P ≥ 0.05) was observed between the wild-type and ddo-3(tm2028) in pharyngeal pumping (as determined by Mann-Whitney U test) or defecation interval, body bends, duration of forward movement, duration of backward movement, anterior body touch, posterior body touch, or male mating efficiency (as determined by unpaired two-tailed t-test). a Significant differences (P < 0.01) vs. the wild-type, as determined by unpaired two-tailed t-test.
Our results also suggest that DDO-3 is secreted from the cells where it is produced into the body fluid and eventually taken up by the coelomocytes (Figs 3B-C 0 , E, E 0 , G-H 0 , 4F, and F 0 ). We previously demonstrated that D-Glu, D-Asp, and D-Ala are present in Escherichia coli strain OP50, which is used as a food source for C. elegans, and that D-Glu content is elevated in the ddo-3 mutant, but not the ddo-1 or ddo-2 mutant [22] . Therefore, it appears that the D-Glu detected in C. elegans is, at least in part, derived from the diet, and that food-derived D-Glu is degraded primarily by DDO-3. Because DDO-3 is not localized to the intestine (Figs 3A-C 0 , E, E 0 , G-H 0 , and 4E-F 0 ), food-derived D-Glu is most likely to be transferred from the intestine into the body fluid, where it is degraded by secreted DDO-3.
ddo-3(tm2028); Ex[Pddo-3::ddo-3 SP(−)] #1 (20.4) ddo-3(tm2028); Ex[Pddo-3::ddo-3 SP(−)] #2 (21.3) ddo-3(tm2028); Ex[Pddo-3::ddo-3 SP(−)] #3 (19.2)
The escape response to nose touch in C. elegans is mediated by the sensory neuron ASH [35] , which signals the touch to the command interneurons via glutamatergic synapses [36, 37] . Defects in the nose touch response caused by mutations that reduce L-Glu release or response are partially restored by a defect in GLT-3, a protein that transports L-Glu from the body fluid into the body-spanning excretory canal cell; loss of GLT-3 function results in elevation of extracellular L-Glu content [38] . In the context of this finding, DDO-3 secreted into the body fluid is presumed to be involved in the L-Glu-mediated neurotransmission required for normal nose touch response. Specifically, a-ketoglutarate produced from D-Glu by DDO-3 in the body fluid can be utilized for the synthesis of L-Glu, which mediates the glutamatergic neurotransmission related to the nose touch response. Accordingly, the weakening of the nose touch response observed in the ddo-3 mutant (Fig. 5C ) may be due to the decrease in a-ketoglutarate production in the body fluid, leading to a decrease in the L-Glu signaling required for this response.
Several lines of evidence suggest that the reduction of global translation rates lowers the intracellular accumulation of damaged or misfolded proteins and promotes homeostatic proteolytic and chaperone functions, resulting in elevated stress resistance and lifespan in C. elegans [39] . Interestingly, the content of L-tryptophan (L-Trp) increases significantly throughout development in the ddo-3 mutant, which has an extended lifespan [22] , even though the recombinant DDO-3 expressed in E. coli exhibits no degradative activity toward L-Trp (data not shown). Knockdown of tryptophan 2,3-dioxygenase, a degradative enzyme of L-Trp, leads to an increase in L-Trp levels, as well as extended lifespan and protection against proteotoxicity, in C. elegans [40] . Furthermore, individual supplementation with optimal concentrations of various amino acids, including L-Trp and D-Glu, extends the lifespan of C. elegans in a manner that depends on the GCN2 kinase [41] . GCN2 senses amino acid starvation by binding uncharged tRNAs, and activated GCN2 inhibits protein synthesis [42] . These observations suggest that a low to moderate degree of amino acid imbalance hinders the correct charging of tRNAs, thereby activating GCN2, and that the resultant slower rate of translation extends the lifespan. In contrast, a high degree of amino acid imbalance shortens lifespan by toxically decreasing the translation rate [41] . Therefore, the extended lifespan of the ddo-3 mutant (Fig. 5D ) may be due to accumulation of L-Trp and/ or D-Glu and the resultant reduction in translation rates. However, it remains unclear where (i.e., in which tissue) secreted DDO-3 exerts a function that affects lifespan in C. elegans. Rescue experiments using tissuespecific DDO-3-expressing transgenes should help to elucidate the relationship between localization of DDO-3 and lifespan.
In DDO-deficient mice, the levels of D-Asp in brain tissues, peripheral tissues, and physiological fluids are much higher than those in wild-type mice, whereas the amounts of D-Glu in the kidney and liver do not differ significantly [21] . On the other hand, we recently demonstrated that a novel mitochondrial gene, 9030617O03Rik, encodes D-Glu cyclase, which reversibly converts D-Glu to 5-oxo-D-proline, and that D-Glu content is significantly higher in D-Glu cyclase-deficient mouse hearts than in wild-type mouse hearts [43] . Thus, in mammals D-Glu is degraded by D-Glu cyclase, but not by DDO. In contrast, no homolog of mammalian D-Glu cyclase is encoded in the C. elegans genome. Moreover, as described above, it is likely that DGlu is degraded primarily by DDO-3 in C. elegans. Indeed, DDO-3, as well as DDO-1 and DDO-2, exhibit higher catalytic efficiency for D-Glu than D-Asp, whereas mammalian DDO exhibits relatively low catalytic efficiency for D-Glu [25] . Collectively, these observations indicate that the metabolic pathways of D-Glu differ between mammals and C. elegans.
In this study, we demonstrated that C. elegans DDO-3 is a secreted DDO isoform, the first such enzyme reported in eukaryotes. DDO homologs with a putative SP but no putative PTS1 motif are found only in nematodes. On the other hand, it was recently proposed that, in mammals, D-amino acids produced by gut microbiota are degraded by D-amino acid oxidase (another D-amino acid-degrading enzyme) secreted from intestinal epithelial cells into the lumen, resulting in the production of H 2 O 2 that inhibits the growth of certain types of pathogenic bacteria [44] . Notably in this regard, the SignalP 3.0 server [45] predicted the presence of an N-terminal SP in mammalian DDO and D-amino acid oxidase, which also contain a C-terminal PTS1 domain. This kind of DDO/D-amino acid oxidase is widely conserved in a variety of eukaryotes, including C. elegans; indeed, the SignalP 3.0 server predicts the presence of an N-terminal SP in C. elegans DDO-1 and D-amino acid oxidase, which also have a C-terminal PTS1 motif. Therefore, it is likely that these enzymes are also secreted in a SPdependent manner. However, in the primary structures of these enzymes, the FAD-binding consensus sequence overlaps with the putative SP. Therefore, it remains uncertain whether these enzymes are in fact secreted to the extracellular space in a SP-dependent manner while maintaining their enzyme activities. To address this issue, we are currently investigating the expression and localization patterns of C. elegans DDO-1 and D-amino acid oxidase.
Materials and methods

Caenorhabditis elegans strains
The Bristol strain N2 was kindly provided by the Caenorhabditis Genetic Center (University of Minnesota, Minneapolis, USA) and used as the standard wild-type strain. The mutant strains EU31 skn-1(zu135)/nT1 and ddo-3(tm2028) were kindly provided by the Caenorhabditis Genetic Center and the National Bioresource Project (Tokyo Women's Medical University, Tokyo, Japan) [46] , respectively. Unless otherwise noted, all strains were grown at 20°C on E. coli strain OP50 [47] .
Construction of reporter and transgene plasmids and generation of transgenic strains
The promoterless mCherry (a red fluorescent protein) reporter vector pAV1997 was a kind gift from Dr. Gary Silverman (Addgene plasmid #37831) [48] . To generate the ddo-3 promoter-mCherry construct (Pddo-3::mCherry reporter), a 2374-bp genomic DNA fragment upstream of the ddo-3 initiation codon was amplified by PCR using wild-type worm genomic DNA as the template and primers 5 0 -CCC GGG CCT TGA ACT ATT GTT TGT ACA TAC-3 0 (forward) and 5 0 -GCT AGC ACC ACC TGC GAT TAA-3 0 (reverse), which contain additional XmaI and NheI sites at the 5 0 ends of the forward and reverse primers, respectively. PCR products were cloned into vector pTA2 (Toyobo, Osaka, Japan), and the construct was confirmed by sequencing (pTA2-Pddo-3). Subsequently, the XmaI-NheI fragment of pTA2-Pddo-3 was subcloned into vector pAV1997, yielding the Pddo-3::mCherry reporter plasmid (pAV-Pddo-3-mCherry). To generate the ddo-3 promoter-DDO-3-mCherry fusion construct lacking the SP [ddo-3 SP(À)::mCherry reporter], a full-length ddo-3 genomic DNA fragment, lacking the putative SP sequence, was amplified by PCR using wild-type worm genomic DNA as the template and primers PCR products were cloned into vector pTA2, and the construct was confirmed by sequencing (pTA2-Pddo-3-ddo-3). Subsequently, the XmaI-NheI fragment of pTA2-Pddo3-ddo-3 was subcloned into vector pAV1997, yielding the ddo-3::mCherry reporter plasmid (pAV-Pddo-3-ddo-3-mCherry).
Germline transgene experiments were performed as described previously [22, 49] . Briefly, transgenic lines were generated by injecting 50 ngÁlL À1 pAV-Pddo-3-mCherry, pAV-Pddo-3-ddo-3 SP(À)-mCherry, or pAV-Pddo-3-ddo-3-mCherry, along with 50 ngÁlL À1 pRF4[rol-6(su1006)] as the transformation marker, into the gonads of wild-type hermaphrodites. Transgenic worms were identified based on the roller phenotype caused by plasmid pRF4[rol-6 (su1006)], and stable lines were isolated. Construction of the following three plasmids was described previously [22] : pT7-Pddo-3, in which a 2374-bp genomic DNA fragment upstream of the ddo-3 initiation codon was cloned into pT7Blue (Novagen, Madison, USA); pT7-Pddo-3-DDO-3, in which the ddo-3 promoter and entire ddo-3 coding sequence was cloned into pT7Blue; and pPD-Pddo-3-GFP, in which the ddo-3 promoter sequence was cloned into the promoterless GFP reporter vector pPD95.67. To construct the expression plasmid for DDO-3 lacking the SP sequence [ddo-3 SP(À) transgene] for use in rescue experiments, a full-length ddo-3 coding sequence lacking the SP sequence was amplified by PCR using first-strand wild-type worm cDNA as the template and primers 5 0 -GCC GGG TAC CGT GAG CTC GTT ACG AGT TGC-3 0 (forward) and 5 0 -GCC GGG TAC CCT AAT CAT CAA GAT ATT TAA CCC-3 0 (reverse), which contain additional KpnI sites at their 5 0 ends. The PCR products were cloned into vector pTA2, and the construct was confirmed by sequencing [pTA2-DDO-3 SP(À)]. Subsequently, the KpnI-KpnI fragment of pTA2-DDO-3 SP (À) was subcloned into pT7-Pddo-3, yielding the ddo-3 SP (À) transgene plasmid [pT7-Pddo-3-DDO-3 SP(À)]. For rescue experiments, transgenic lines were generated by injecting 50 ngÁlL À1 pT7-Pddo-3-DDO-3 or pT7-Pddo-3-DDO-3 SP(À), along with 50 ngÁlL À1 pPD-Pddo-3-GFP as the transformation marker, into the gonads of ddo-3 (tm2028) hermaphrodites. Transgenic worms were identified by the expression of GFP from plasmid pPD-Pddo-3-GFP, and stable lines were isolated. 
Microscopic analysis
Assays for behavioral phenotypes
Pharyngeal pumping
Pharyngeal pumping rates were measured as described [50] with some modifications. Briefly, adult hermaphrodites grown at 25°C (the day after larval stage late L4) were individually placed onto agar plates seeded with thick bacterial lawns. The pharynx of each worm was video recorded for 10 s under a M205 C stereomicroscope equipped with a MC170 HD camera (Leica, Wetzlar, Germany). Pumping rates were measured by counting grinder movements using the slow-motion video replay.
Defecation interval
Worm defecation is carried out by three distinct motor steps: posterior body muscle contraction (pBoc), anterior body muscle contraction (aBoc), and expulsion muscle contraction (EMC) [51] . For measurement of the defecation interval, adult hermaphrodites grown at 25°C were individually placed onto agar plates seeded with thick bacterial lawns. For each worm, the period required for 10 consecutive defecation cycles was measured under the stereomicroscope. Based on these measurements, the time of a defecation interval (from one pBoc to the next pBoc) was calculated.
Body bend
Adult hermaphrodites grown at 25°C were individually placed onto food-free agar plates. Body bends were counted for 2 min under the stereomicroscope, and this value was used to calculate the number of body bends per minute. A body bend was defined as maximum flexure of the body just behind the pharynx in the direction opposite to the previously scored bend.
Duration of forward and backward movements
Adult hermaphrodites grown at 25°C were individually placed onto food-free agar plates. The periods required for the forward and backward movements, respectively, were measured for more than 3 min under the stereomicroscope, and the duration of one respective movement was calculated.
Nose touch response
Nose touch assays were performed as described [35] with some modifications. Briefly, adult hermaphrodites grown at 25°C were individually placed onto food-free agar plates. A fine hair was placed on the surface of the agar in front of the path of the worm, which was observed under the stereomicroscope. The number of resultant backing responses in eight consecutive trials was measured for each worm. For the rescue experiment, adult hermaphrodites grown at 20°C (2 days after the larval stage late L4) were used.
Anterior and posterior body touch responses
Anterior and posterior body touch assays were performed as described [52] with some modifications. Briefly, adult hermaphrodites grown at 25°C were individually placed onto agar plates seeded with thin bacterial lawns. To evoke the anterior and posterior body touch responses, the worms were touched by stroking an eyelash across the body just behind the pharynx and just before the anus, respectively. Worms were observed under the stereomicroscope. The numbers of the resultant backward and forward movements in five consecutive trials were measured for each worm.
Male mating efficiency
Young adult virgin males were placed with wild-type late L4 larva hermaphrodites in one-to-one crosses on agar plates seeded with a tiny spot of bacteria. Plates were incubated at 20°C. The worms were transferred to fresh agar plates once a day for 3 days. Total male progeny were counted after the worms reached the adult stage. Because the ratio of the two sexes (hermaphrodite and male) among cross-progeny is 1 : 1, the number of cross-progeny was calculated by doubling the number of male progeny. Not less than 99% of eggs laid hatched under these culture conditions.
Assays for developmental phenotypes
Self-brood size
Late L4 larva hermaphrodites were individually placed onto seeded agar plates and incubated at 20°C. The worms were transferred daily to fresh agar plates until no more eggs were laid. Total progeny were counted after the worms reached the L4 stage. In all strains tested, not less than 99% of the eggs laid hatched under these culture conditions.
Hatching rate
Late L4 larva hermaphrodites were placed onto seeded agar plates and incubated at 25°C for 24 h. The worms were individually transferred to fresh agar plates, allowed to lay eggs at 25°C for 6 h, and removed. The eggs were counted and further incubated at 25°C. The hatched progeny was counted after the worms reached the L4 stage. The proportion of progeny worms in the brood was defined as the hatching rate.
Lifespan
Synchronized young adult worms were transferred to seeded agar plates containing 50 lM 5-fluoro-2 0 -deoxyuridine to prevent progeny from hatching. The worms were incubated at 20°C, and survival was monitored every 1-2 days. Worms that did not respond to prodding with a platinum wire were scored as dead and removed. Bagged and exploded worms were excluded from the analysis.
Statistical analysis
To evaluate the statistical significance of differences between two means, data were analyzed by unpaired twotailed t-test. When the variance differed between the two groups, the Mann-Whitney U test was used instead. To evaluate the statistical significance of differences among three or more means, data were analyzed by the TukeyKramer test. When the variance differed among the groups, the Steel-Dwass test was used instead. To evaluate the statistical significance of differences in lifespan among the groups, data were analyzed by log-rank test.
